Steven Ledbetter

Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance

Masaki Terabe, So Matsui, Jong-Myun Park et al. · The Journal of Experimental Medicine · 2003 · 533 citations · Full text

Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2

Masato Kato, Huiming Wang, Varpu Kainulainen et al. · Nature Medicine · 1998 · 339 citations

Signal Transduction, Molecular Physiology, Soluble Syndecan-1 Ectodomain +15

Isoform-Specific Activation of Latent Transforming Growth Factor β (LTGF-β) by Reactive Oxygen Species

Michael F. Jobling, Joni D. Mott, MONICA T. FINNEGAN et al. · Radiation Research · 2006 · 284 citations

Human Growth, Tgf-β Bioavailability, Cell Growth +20

Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine

Nikolay O. Bukanov, Laurie A. Smith, K. Klinger et al. · Nature · 2006 · 270 citations

Urology, Renal Function, Medicine +11

Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy

Yves Sabbagh, Fabiana G. Graciolli, Stephen O’Brien et al. · Journal of Bone and Mineral Research · 2012 · 252 citations · Full text